LFG
KNSA icon

Larson Financial Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Larson Financial Group’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$50.5K Buy
1,048
+636
+154% +$28.2K ﹤0.01% 1347
2025
Q4 		$17K Buy
412
+75
+22% +$3.01K ﹤0.01% 1808
2025
Q3 		$13.1K Buy
+337
New +$10.9K ﹤0.01% 1882
2025
Q2 		– Sell
-33
Closed -$733 – 3400
2025
Q1 		$733 Buy
+33
New +$679 ﹤0.01% 2470

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Larson Financial Group's KNSA Position: Q1 2026 in Review

Larson Financial Group increased its Kiniksa Pharmaceuticals (KNSA) stake by 154% in Q1 2026, buying an estimated $28.2K and bringing the position to 1,048 shares worth $50.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1347.

Larson Financial Group first reported a position in KNSA in Q1 2025 and has held it in 4 quarters since. 228 funds tracked by Wall St. Rank hold KNSA as of Q1 2026.

  • Larson Financial Group held 1,048 shares of Kiniksa Pharmaceuticals worth $50.5K as of Q1 2026.
  • Larson Financial Group bought 636 Kiniksa Pharmaceuticals shares in Q1 2026, an estimated $28.2K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #1347 holding.
  • Larson Financial Group first reported a position in Kiniksa Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • 228 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.